Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Christopher A Marlett is Director at Mdb Capital Holdings, LLC. OQRO lists 31 transactions filed with the SEC under this name, the latest on Oct 19, 2026, each linked to the official Form 4.
Director
Disclosures on record
31
Companies involved
2
15 buys, median −19.5 pts vs S&P 500, beat it 1 of 15 times.
Average −15.5 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Apr 9, 2025 to Jan 6, 2026, measured from the first close after the filing. Past results, not a forecast.
17 purchases disclosed; 7% of the 15 measured at 90 days finished ahead of the index. $1,000 placed after each of the 4 purchases disclosed since 2025-11-14 would be worth $2.5K today ($4K put in); the same in the S&P 500 (SPY): $4.2K.
Rank 71 of the 82 insiders with at least 10 purchases measured at 90 days. The middle of that group is −5.5 pts (median, against the S&P 500).
ExozymesEXOZ
Oct 1, 202610Kdisclosed Oct 19
DetailsOfficial recordMdb Capital Holdings, LLCMDBH
30 disclosures · Apr 2025 – Oct 2026 · 29 bought
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Oct 13, 2026Bought~$20Kdisclosed Oct 15
DetailsOfficial recordMay 1, 2026100Kdisclosed May 4
DetailsOfficial recordJan 2, 2026Bought~$4.2Kdisclosed Jan 6
DetailsOfficial recordDec 31, 2025Bought~$15K
DetailsOfficial recordDec 30, 2025Bought~$14Kdisclosed Dec 31
DetailsOfficial recordAug 28, 2025Bought~$5.6Kdisclosed Aug 30
DetailsOfficial recordAug 29, 2025Bought~$5.8Kdisclosed Aug 30
DetailsOfficial recordAug 26, 2025Bought~$4.7Kdisclosed Aug 27
DetailsOfficial recordAug 27, 2025Bought~$4.4K
DetailsOfficial recordAug 25, 2025Bought~$4.1Kdisclosed Aug 27
DetailsOfficial recordAug 21, 2025Bought~$4.1Kdisclosed Aug 22
DetailsOfficial recordAug 22, 2025Bought~$4K
DetailsOfficial recordJul 14, 2025Bought~$442disclosed Jul 16
DetailsOfficial recordJun 25, 2025Bought~$9disclosed Jun 26
DetailsOfficial recordJun 26, 2025Bought~$99
DetailsOfficial recordJun 24, 2025Bought~$89disclosed Jun 26
DetailsOfficial recordJun 20, 2025Bought~$3.7Kdisclosed Jun 24
DetailsOfficial recordJun 23, 2025Bought~$2.8Kdisclosed Jun 24
DetailsOfficial recordJun 18, 2025Bought~$2.6Kdisclosed Jun 20
DetailsOfficial recordJun 12, 2025Bought~$5Kdisclosed Jun 13
DetailsOfficial recordJun 11, 2025Bought~$4.9Kdisclosed Jun 13
DetailsOfficial recordJun 10, 2025Bought~$5Kdisclosed Jun 11
DetailsOfficial recordJun 9, 2025Bought~$50disclosed Jun 11
DetailsOfficial recordMay 30, 2025Bought~$5.1Kdisclosed Jun 3
DetailsOfficial recordJun 2, 2025Bought~$5.2Kdisclosed Jun 3
DetailsOfficial recordMay 29, 2025Bought~$4.8Kdisclosed May 30
DetailsOfficial recordMay 28, 2025Bought~$5Kdisclosed May 30
DetailsOfficial recordApr 11, 2025Bought~$8.1Kdisclosed Apr 15
DetailsOfficial recordApr 7, 2025Bought~$6.8Kdisclosed Apr 9
DetailsOfficial recordAs of the latest filing on , Christopher A Marlett reported holding 334,783 shares of Mdb Capital Holdings, LLC (MDBH), worth about $503K at the last close of $2 (Nov 13, 2026): 180,850 held directly and 153,933 through a cust. In the last 12 months, Christopher A Marlett bought $55K in 5 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Mdb Capital Holdings, LLC MDBH | 334,783 | 181K direct · 154K cust | $2 | $503K | Oct 15, 2026 |
Is this Christopher A Marlett’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Christopher A Marlett bought shares on the open market in 2017, 2018, 2025 and 2026 across 3 companies. Sales in 1 of the 10 years since 2017.
Christopher A Marlett reported 50 open-market purchases and 7 sales since 2017; purchases in 4 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $26K3×3 trades | — |
| 2025 | $121K26×26 trades | — |
| 2019 | — | $1.43M7×7 trades |
| 2018 | $463K10×10 trades | — |
| 2017 | $229K11×11 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Oct 15, 2026, Christopher A Marlett reported holding 334,783 shares of Mdb Capital Holdings, LLC (MDBH), of which 153,933 are held indirectly. At the last close of $2 on Nov 13, 2026, that is about $503K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Christopher A Marlett reported 5 open-market purchases worth $55K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Christopher A Marlett bought shares on the open market in 2017, 2018, 2025 and 2026 across 3 companies. Sales in 1 of the 10 years since 2017.
In SEC filings since 2017: the latest open-market purchase is from 2026; the latest open-market sale is from 2019.
3 companies: Mdb Capital Holdings, LLC (MDBH, 2025–2026), Cue Biopharma (CUE, 2018–2019), Paradium.ai (PAAI, 2017).
Christopher A Marlett reported 29 open-market purchases and 0 sales here, 2025 to 2026.
Christopher A Marlett reported 10 open-market purchases and 7 sales here, 2018 to 2019.
Christopher A Marlett reported 11 open-market purchases and 0 sales here, 2017.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.